Global Hormonal Contraceptives Market Share

Statistics for the 2023 & 2024 Global Hormonal Contraceptives market share, created by Mordor Intelligence™ Industry Reports. Global Hormonal Contraceptives share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Hormonal Contraceptives Industry

The hormonal contraceptives market is fragmented in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known. The key market players are Allergan plc, Afaxys, Inc., Merck & Co., Inc., Pfizer Inc., Viatris Inc (Mylan N.V.), Bayer AG, Agile Therapeutics, Novartis AG, Johnson & Johnson Private Limited, and Piramal Enterprises Ltd. among others.

Hormonal Contraceptives Market Leaders

  1. Allergan plc

  2. Afaxys, Inc.

  3. Merck & Co., Inc.

  4. Pfizer Inc.

  5. Mylan N.V.

*Disclaimer: Major Players sorted in no particular order

Picture2.png

Hormonal Contraceptives Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)